Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.

Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; 'Back to Top' was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:31:07.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:38:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has added significant information regarding a facility, its location, and relevant publications, while removing specific geographic details and references to eczema.
    Difference
    5%
    Check dated 2025-08-31T12:08:53.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-17T04:35:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:28:44.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T18:59:43.000Z thumbnail image

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.